148 related articles for article (PubMed ID: 21407030)
1. Promoting access and reducing expected out-of-pocket prescription drug costs for vulnerable Medicare beneficiaries: a pharmacist-directed model.
Cutler TW; Stebbins MR; Smith AR; Patel RA; Lipton HL
Med Care; 2011 Apr; 49(4):343-7. PubMed ID: 21407030
[TBL] [Abstract][Full Text] [Related]
2. Cost minimization of medicare part D prescription drug plan expenditures.
Patel RA; Lipton HL; Cutler TW; Smith AR; Tsunoda SM; Stebbins MR
Am J Manag Care; 2009 Aug; 15(8):545-53. PubMed ID: 19670958
[TBL] [Abstract][Full Text] [Related]
3. Impact of cost sharing on prescription drugs used by Medicare beneficiaries.
Goedken AM; Urmie JM; Farris KB; Doucette WR
Res Social Adm Pharm; 2010 Jun; 6(2):100-9. PubMed ID: 20511109
[TBL] [Abstract][Full Text] [Related]
4. It pays to compare: assisting Medicare Part D beneficiaries with enrollment yields out-of-pocket cost savings.
Geonnotti KL; Upchurch G; Roth MT; Weinberger M
J Am Geriatr Soc; 2011 May; 59(5):953-5. PubMed ID: 21568975
[No Abstract] [Full Text] [Related]
5. Can a pharmacist reduce annual costs for Medicare Part D enrollees?
Alston G; Hanrahan C
Consult Pharm; 2011 Mar; 26(3):182-9. PubMed ID: 21402518
[TBL] [Abstract][Full Text] [Related]
6. Potential impact of pharmacist interventions to reduce cost for Medicare Part D beneficiaries.
Thatcher EE; Vanwert EM; Erickson SR
J Pharm Pract; 2013 Jun; 26(3):248-52. PubMed ID: 23178417
[TBL] [Abstract][Full Text] [Related]
7. PDP or MA-PD? Medicare part D enrollment decisions in CMS Region 25.
Cline RR; Worley MM; Schondelmeyer SW; Schommer JC; Larson TA; Uden DL; Hadsall RS
Res Social Adm Pharm; 2010 Jun; 6(2):130-42. PubMed ID: 20511112
[TBL] [Abstract][Full Text] [Related]
8. Variation in Prescription Drug Coverage Enrollment Among Vulnerable Beneficiaries With Glaucoma Before and After the Implementation of Medicare Part D.
Blumberg DM; Prager AJ; Liebmann JM
JAMA Ophthalmol; 2016 Feb; 134(2):212-20. PubMed ID: 26720853
[TBL] [Abstract][Full Text] [Related]
9. Should healthy Medicare beneficiaries postpone enrollment in Medicare Part D?
Atherly A; Dowd B
Health Econ; 2009 Aug; 18(8):921-31. PubMed ID: 18972327
[TBL] [Abstract][Full Text] [Related]
10. Minimizing out-of-pocket prescription drug costs for Medicare beneficiaries: not just 'a drop in the bucket'.
Patel RA; Vo KA; Chu T; Wang K; Lu S; Woelfel JA; Carr-Lopez SM; Galal SM
J Am Pharm Assoc (2003); 2014; 54(6):604-9. PubMed ID: 25379981
[TBL] [Abstract][Full Text] [Related]
11. Out-of-pocket health spending by poor and near-poor elderly Medicare beneficiaries.
Gross DJ; Alecxih L; Gibson MJ; Corea J; Caplan C; Brangan N
Health Serv Res; 1999 Apr; 34(1 Pt 2):241-54. PubMed ID: 10199672
[TBL] [Abstract][Full Text] [Related]
12. Why using current medications to select a medicare Part D plan may lead to higher out-of-pocket payments.
Domino ME; Stearns SC; Norton EC; Yeh WS
Med Care Res Rev; 2008 Feb; 65(1):114-26. PubMed ID: 17942795
[TBL] [Abstract][Full Text] [Related]
13. The Medicare Part D doughnut hole: effect on pharmacy utilization.
Sun SX; Lee KY
Manag Care Interface; 2007 Sep; 20(9):51-5, 59. PubMed ID: 18161394
[TBL] [Abstract][Full Text] [Related]
14. Effect of Medicare Part D and insurance type on Medicare beneficiary access to prescription medication and use of prescription cost-saving measures.
Urmie JM; Farris KB; Doucette WR; Goedken AM
J Am Pharm Assoc (2003); 2011; 51(1):72-81. PubMed ID: 21247829
[TBL] [Abstract][Full Text] [Related]
15. Medicare Part D: selected issues for plan sponsors, pharmacists, and beneficiaries in 2009.
Stubbings J; DePue RJ
Am J Manag Care; 2009 Sep; 15(9):645-9. PubMed ID: 19747029
[TBL] [Abstract][Full Text] [Related]
16. Patterns of prescription drug expenditures and medication adherence among medicare part D beneficiaries with and without the low-income supplement.
Yala SM; Duru OK; Ettner SL; Turk N; Mangione CM; Brown AF
BMC Health Serv Res; 2014 Dec; 14():665. PubMed ID: 25526892
[TBL] [Abstract][Full Text] [Related]
17. Impact of Medicare Part D on access to and cost sharing for specialty biologic medications for beneficiaries with rheumatoid arthritis.
Polinski JM; Mohr PE; Johnson L
Arthritis Rheum; 2009 Jun; 61(6):745-54. PubMed ID: 19479704
[TBL] [Abstract][Full Text] [Related]
18. Factors associated with independent pharmacy owners' satisfaction with Medicare Part D contracts.
Zhang S; Doucette WR; Urmie JM; Xie Y; Brooks JM
Res Social Adm Pharm; 2010 Jun; 6(2):121-9. PubMed ID: 20511111
[TBL] [Abstract][Full Text] [Related]
19. Should healthy Medicare beneficiaries postpone enrollment in Part D?
Federowicz M
Find Brief; 2008 Nov; 11(9):1-4. PubMed ID: 19035030
[TBL] [Abstract][Full Text] [Related]
20. Who will be denied Medicare prescription drug subsidies because of the asset test?
Rice T; Desmond K
Am J Manag Care; 2006 Jan; 12(1):46-54. PubMed ID: 16402888
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
